CFM
MED icon

Catalyst Funds Management’s Medifast MED Stock Holding History

Catalyst Funds Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,400
Closed -$65.1K – 879
2024
Q3 		$65.1K Hold
3,400
– – 0.01% 669
2024
Q2 		$74.2K Buy
+3,400
New +$90.6K 0.02% 345

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Catalyst Funds Management's MED Position: Q4 2024 in Review

Catalyst Funds Management sold out of Medifast (MED) in Q4 2024, closing a stake of 3,400 shares — an estimated $65.1K sold.

Catalyst Funds Management first reported a position in MED in Q2 2024 and held it in 2 quarters. The position peaked at $74.2K in Q2 2024. 129 funds tracked by Wall St. Rank hold MED as of Q4 2024.

  • Catalyst Funds Management reported no remaining Medifast position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 3,400 Medifast shares in Q4 2024, an estimated $65.1K.
  • Catalyst Funds Management first reported a position in Medifast in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Medifast position peaked at $74.2K in Q2 2024.
  • 129 funds tracked by Wall St. Rank held Medifast as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.